Mutual Fund Research

UTI Healthcare Fund-Reg(G)

As on May-14-2021 change fund
156.91  up-1.54 (-0.97%)

fund objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2016-20172017-20182018-20192019-20202020-2021
NAV in Rs (as on 31-Mar-2021)89.5782.2586.1480.12139.38
Net Assets(Rs Crores) (as on 31-Mar-2021) 325.28 387.31 439.81 360.08 618.13
Scheme Returns(%)(Absolute)4.08-8.883.28-7.1376.19
B'mark Returns(%)(Absolute)1.71-14.457.46-15.0279.08
Category Rank46/5653/6232/7316/7535/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202130.5824.119.54-2.01
2019-2020-7.94-1.668.97-5.72
2018-20190.317.90-5.642.55
2017-2018-5.81-2.5210.45-9.45
2016-20173.784.22-8.434.72
Top 10 holdings
company (%)
Dr. Reddys Laboratories Ltd.9.99 
Aurobindo Pharma Ltd.8.96 
Cipla Ltd.8.69 
Sun Pharmaceutical Industries...8.61 
Divis Laboratories Ltd.5.54 
Cadila Healthcare Ltd.5.39 
Eris Lifesciences Ltd.4.39 
Fortis Healthcare Ltd.4.01 
JB Chemicals & Pharmaceuticals...3.89 
Ajanta Pharma Ltd.3.82 

Category

Sector Funds

Launch Date

01-Aug-05

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

800.02

portfolio price to book value

5.86

investing style?

Large Growth

fund manager?

V. Srivatsa

inception date (regular plan)

01-Aug-05

expense ratio (regular plan) %

2.33

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs85.71
Hospital & Healthcare Services10.46
Medical Equipment/Supplies/Accessories1.67

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005800.0258.1223.9912.3314.5919.04
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,811.5759.5727.3516.4917.8221.88
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015492.0851.3824.3111.34NA9.52
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,748.4059.8123.219.8017.3116.08
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,549.0763.03NANANA26.71
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,236.1361.33NANANA34.44
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,458.9857.87NANANA29.32
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019508.9848.84NANANA37.40
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201972.9144.61NANANA30.89
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.